Immunotherapeutics CMV prevention in transplant Ph II Idiopathic thrombocytopenic purpura (ITP) Ph III Prophylactic RhD isoimmunisation Ph IV Immunosuppression in total body psoriasis Ph III Metastatic melanoma vaccine Ph III
